ATE210149T1 - Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden - Google Patents

Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Info

Publication number
ATE210149T1
ATE210149T1 AT94919428T AT94919428T ATE210149T1 AT E210149 T1 ATE210149 T1 AT E210149T1 AT 94919428 T AT94919428 T AT 94919428T AT 94919428 T AT94919428 T AT 94919428T AT E210149 T1 ATE210149 T1 AT E210149T1
Authority
AT
Austria
Prior art keywords
dynorphine
tyr
analogues
des
inflammatory composition
Prior art date
Application number
AT94919428T
Other languages
English (en)
Inventor
Edward T Wei
Holly A Thomas
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE210149T1 publication Critical patent/ATE210149T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94919428T 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden ATE210149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/074,210 US5482930A (en) 1993-06-09 1993-06-09 Anti-inflammatory composition and method with des-Tyr dynorphin and analogues
PCT/US1994/006502 WO1994029337A1 (en) 1993-06-09 1994-06-09 Anti-inflammatory composition and method with des-tyr dynorphin and analogues

Publications (1)

Publication Number Publication Date
ATE210149T1 true ATE210149T1 (de) 2001-12-15

Family

ID=22118342

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919428T ATE210149T1 (de) 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Country Status (8)

Country Link
US (1) US5482930A (de)
EP (1) EP0751954B1 (de)
JP (1) JPH08511541A (de)
AT (1) ATE210149T1 (de)
AU (1) AU679241B2 (de)
CA (1) CA2164880A1 (de)
DE (1) DE69429365D1 (de)
WO (1) WO1994029337A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7209594A (en) * 1993-06-18 1995-01-17 David F. Counts Anti-inflammatory peptides
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6437092B1 (en) 1998-11-06 2002-08-20 Conjuchem, Inc. Conjugates of opioids and endogenous carriers
US6228840B1 (en) * 1998-02-27 2001-05-08 Edward T. Wei Melanocortin receptor antagonists and modulations of melanocortin receptor activity
AU769198B2 (en) * 1999-03-26 2004-01-22 Regeneron Pharmaceuticals, Inc. Modulation of vascular permeability by means of TIE2 receptor activators
US6706892B1 (en) * 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
EP1402899A4 (de) * 2001-05-08 2009-03-11 Toray Industries Mittel zur behandlung von sepsis
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050143300A1 (en) * 2003-10-10 2005-06-30 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050130897A1 (en) * 2003-12-11 2005-06-16 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
AU2005244852B2 (en) 2004-05-12 2011-09-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
AU2011265315B2 (en) * 2004-05-12 2014-08-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
BRPI0911945A2 (pt) 2008-05-13 2015-10-13 Clarassance Inc cc10 humana recombinante e suas composições para uso no tratamento de rinite nasal
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
CN102834115B (zh) 2009-10-15 2015-01-14 克拉莱森公司 用于治疗流感的重组人cc10蛋白
CN116715726A (zh) * 2022-10-14 2023-09-08 深圳市维琪科技股份有限公司 合成肽及其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4361553A (en) * 1981-05-18 1982-11-30 Regents Of The University Of California Therapeutic uses of dynorphin
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4684624A (en) * 1983-12-22 1987-08-04 Yoshio Hosobuchi Method of treating cerebral ischemia
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
US5177060A (en) * 1990-01-09 1993-01-05 Regents Of The University Of California Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
AU4399093A (en) * 1992-06-12 1994-01-04 Des-Tyr Dynorphin Partnership Des-tyr dynorphin analogues

Also Published As

Publication number Publication date
AU7058394A (en) 1995-01-03
JPH08511541A (ja) 1996-12-03
EP0751954B1 (de) 2001-12-05
AU679241B2 (en) 1997-06-26
EP0751954A4 (de) 1998-06-03
CA2164880A1 (en) 1994-12-22
WO1994029337A1 (en) 1994-12-22
US5482930A (en) 1996-01-09
EP0751954A1 (de) 1997-01-08
DE69429365D1 (de) 2002-01-17

Similar Documents

Publication Publication Date Title
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
PL319608A1 (en) Compositions for treating irds and ards, containing at least one glucocorticosteroid in a mixture with a pulmonic surfactant
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
ITMI912296A0 (it) Nuovi pregna 1,4-diene-3,20.dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
GB9806632D0 (en) Peptide factor
CA2284482A1 (en) Treatment of cardiomyopathy
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
FR2662698B1 (de)
AU5323396A (en) Methods of treating inflammation and compositions therefor
IL132709A0 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
ES8403884A1 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
MY123805A (en) Stabilized pharmaceutical composition based on quinupristine and dalfopristine and their preparation.
MX22991A (es) Agente edulcorante derivado del acido l-aspartico o l-glutamico y el procedimiento para su preparacion.
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
IL139303A0 (en) Treatment of arthritis and other similar conditions
JPS6463342A (en) Stabilization of glutathione-containing composition
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
EP0789031A3 (de)
Danielewski Computer simulation of corrosion processes, contemporary patterns of mass transport processes
JPS5758630A (en) Interferon inducer
RU96100906A (ru) Способ радикального лечения первичного гипотиреоза

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties